PRVAHealthcareMid-Cap

Privia Health Group, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Privia Health Group, Inc. (PRVA), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are PRVA insiders buying or selling?

Privia Health Group, Inc. insiders reported 5 open-market buys ($9.3M) and 203 sells ($4.6B) across 208 Form 4 filings — a net selling position of $4.6B.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 13, 2026)

Total Form 4 filings
208
SEC EDGAR
Insider filers
14
Insider buys (5)
$9.3M
Insider sells (203)
$4.6B

Insider sentiment

Net selling

Net insider flow of $4.6B in net selling.

Recent PRVA insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 13, 2026David MountcastleEVP & Chief Financial OfficerSale21.3K$27.67$588.7K
Jul 9, 2026David MountcastleEVP & Chief Financial OfficerSale600$27.57$16.5K
Jul 7, 2026Matthew Shawn MorrisDirectorSale112.8K$27.29$3.1M
Jul 7, 2026David MountcastleEVP & Chief Financial OfficerSale24.7K$27.50$680.2K
Jul 2, 2026Matthew Shawn MorrisDirectorSale135.5K$26.32$3.6M
Jun 30, 2026Matthew Shawn MorrisDirectorSale151.3K$25.33$3.8M
Jun 30, 2026David MountcastleEVP & Chief Financial OfficerSale17.2K$25.18$433.0K
May 13, 2026Parth MehrotraChief Executive OfficerSale121.1K$22.56$2.7M
May 13, 2026David MountcastleEVP & Chief Financial OfficerSale3.4K$22.60$76.5K
May 6, 2026David MountcastleEVP & Chief Financial OfficerSale8.4K$25.03$209.8K
May 5, 2026Matthew Shawn MorrisDirectorSale18.1K$24.99$452.6K
Apr 6, 2026David MountcastleEVP & Chief Financial OfficerSale5.6K$20.85$116.1K
Mar 18, 2026David MountcastleEVP & Chief Financial OfficerSale6.4K$22.11$141.3K
Mar 18, 2026Parth MehrotraChief Executive OfficerSale26.5K$22.11$586.1K
Mar 16, 2026David MountcastleEVP & Chief Financial OfficerSale13.0K$21.71$282.6K
Mar 16, 2026Parth MehrotraChief Executive OfficerSale54.0K$21.71$1.2M
Mar 12, 2026Parth MehrotraChief Executive OfficerSale21.1K$22.71$479.1K
Mar 10, 2026Parth MehrotraChief Executive OfficerSale63.4K$22.95$1.5M
Mar 10, 2026Edward C FargisEVP & General CounselSale9.3K$22.99$214.8K
Mar 10, 2026David MountcastleEVP & Chief Financial OfficerSale11.0K$22.99$253.0K
Mar 2, 2026Matthew Shawn MorrisDirectorSale24.3K$25.00$608.4K
Mar 2, 2026David MountcastleEVP & Chief Financial OfficerSale13.1K$25.03$326.8K
Dec 16, 2025Matthew Shawn MorrisDirectorSale13.6K$25.01$341.3K
Dec 16, 2025David MountcastleEVP & Chief Financial OfficerSale23.9K$25.03$597.9K
May 14, 2025Parth MehrotraChief Executive OfficerSale29.7K$24.74$734.3K

Showing the 25 most recent of 208 Form 4 filings for Privia Health Group, Inc..

Most active PRVA insiders

  • Parth Mehrotra49 filings
  • Sullivan William M38 filings
  • David Mountcastle34 filings
  • Matthew Shawn Morris27 filings
  • Thomas Bartrum25 filings

Ask anything about PRVA insider activity

Use Trabud's AI agent to query Privia Health Group, Inc.'s Form 4 history in plain English — "Show me PRVA CEO purchases this year" or compare it against any other ticker.

Open the AI agent

PRVA insider trading FAQ

Are Privia Health Group, Inc. insiders buying or selling?

Across 208 SEC Form 4 filings, Privia Health Group, Inc. (PRVA) insiders reported 5 open-market purchases totaling $9.3M and 203 sales totaling $4.6B. That is a net selling position of $4.6B.

How many insiders trade PRVA stock?

14 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Privia Health Group, Inc.. The most recent filing was accepted on Jul 13, 2026.

Where does Trabud get PRVA insider trading data?

All PRVA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content